In this study, the frequency of FGFR2 rearrangement-positive cases was 7.4% among patients with advanced/recurrent ICC, which was lower than those of previous reports (13–14%) that analyzed surgically resected cases [12, 14]. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.